Conversely, the tumors might mutate to "escape" the immune onslaught engendered by a dendritic cell vaccine. 反之，肿瘤可能也会产生突变，因而躲过树突细胞疫苗引发的免疫攻击。
When injected back into the patients, the antigen-loaded dendritic cells are expected to ramp up patients' immune response against their own tumors. 若把这些载满抗原的树突细胞注射回患者体内，预料这些细胞将可加强患者本身的免疫反应，来对抗自身的肿瘤。
